Literature DB >> 2713856

Association of lysosomal activity with sensitivity and resistance to tumor necrosis factor in murine L929 cells.

J D Liddil1, R T Dorr, P Scuderi.   

Abstract

The cytotoxic mechanism of action of tumor necrosis factor (TNF) was examined using murine L929 fibrosarcoma cells in vitro. Two cell lines were evaluated: parental TNF sensitive (L929S) (50% cytotoxic concentration, 2-6 ng/ml); and TNF resistant (L929R) (50% cytotoxic concentration, greater than 10,000 ng/ml). The latter resistant cell line was developed by serial passage in increasing concentrations of recombinant human TNF. Sensitive cells demonstrated cytolytic and cytostatic effects at TNF concentrations between 2 and 6 ng/ml, respectively. However, TNF failed to show any selective depression of RNA, DNA, or protein synthesis or ATP content in these cells until general cell death was apparent, as defined by the cell rounding and lifting off the plastic surface. The cytokine also failed to cause DNA single-strand breaks, as detected by alkaline elution techniques. TNF was also found to be no more active in glutathione-depleted cells than in target cells containing normal glutathione levels. In contrast, various nonspecific lysosomotropic agents such as ammonium chloride and D-saccharic acid lactone led to a marked inhibition of the cytotoxic action of TNF in vitro. Furthermore, significant differences in lysosomal enzyme activity were noted between L929S and L929R cells. The changes in L929R cells involved a 50% reduction in total lysosomal protein levels and a marked depression of beta-glucuronidase activity. In contrast, L929R lysosomal hexosaminidase activity was significantly elevated over the L929S cells. From these studies it is concluded that the antitumor activity of TNF does not involve specific inhibition of macromolecular synthesis, ATP production, or the level of reduced thiols. Instead, TNF cytotoxicity appears to require functional lysosomes, which are altered when TNF resistance develops in vitro.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2713856

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  11 in total

Review 1.  Programmed necrosis: backup to and competitor with apoptosis in the immune system.

Authors:  Jiahuai Han; Chuan-Qi Zhong; Duan-Wu Zhang
Journal:  Nat Immunol       Date:  2011-11-16       Impact factor: 25.606

2.  Resistance to tumor necrosis factor-induced cell death mediated by PMCA4 deficiency.

Authors:  K Ono; X Wang; J Han
Journal:  Mol Cell Biol       Date:  2001-12       Impact factor: 4.272

3.  Mononuclear phagocyte hydrolytic enzyme activity associated with cerebral HIV-1 infection.

Authors:  B B Gelman; D A Wolf; M Rodriguez-Wolf; A B West; A K Haque; M Cloyd
Journal:  Am J Pathol       Date:  1997-11       Impact factor: 4.307

4.  Induction of sensitivity to the cytotoxic action of tumor necrosis factor alpha by adenovirus E1A is independent of transformation and transcriptional activation.

Authors:  R S Ames; B Holskin; M Mitcho; D Shalloway; M J Chen
Journal:  J Virol       Date:  1990-09       Impact factor: 5.103

5.  Three-in-one chromatography-free purification, tag removal, and site-specific modification of recombinant fusion proteins using sortase A and elastin-like polypeptides.

Authors:  Joseph J Bellucci; Miriam Amiram; Jayanta Bhattacharyya; Dewey McCafferty; Ashutosh Chilkoti
Journal:  Angew Chem Int Ed Engl       Date:  2013-02-19       Impact factor: 15.336

6.  Structural changes of tumor necrosis factor alpha associated with membrane insertion and channel formation.

Authors:  R L Baldwin; M L Stolowitz; L Hood; B J Wisnieski
Journal:  Proc Natl Acad Sci U S A       Date:  1996-02-06       Impact factor: 11.205

7.  Comparison of the intoxication pathways of tumor necrosis factor and diphtheria toxin.

Authors:  M P Chang; B J Wisnieski
Journal:  Infect Immun       Date:  1990-08       Impact factor: 3.441

8.  Susceptibility of lysosomes to rupture is a determinant for plasma membrane disruption in tumor necrosis factor alpha-induced cell death.

Authors:  Koh Ono; Sung O Kim; Jiahuai Han
Journal:  Mol Cell Biol       Date:  2003-01       Impact factor: 4.272

9.  Enhancement of lysosomal enzyme activity by recombinant human tumor necrosis factor and its role in tumor cell killing in vitro.

Authors:  N Watanabe; N Yamauchi; H Neda; M Maeda; Y Tsuji; T Okamoto; S Akiyama; H Sasaki; N Tsuji; Y Niitsu
Journal:  Jpn J Cancer Res       Date:  1992-06

Review 10.  Trastuzumab emtansine: mechanisms of action and drug resistance.

Authors:  Mark Barok; Heikki Joensuu; Jorma Isola
Journal:  Breast Cancer Res       Date:  2014-03-05       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.